Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan D Spicer

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung CancerPatrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.
Nature Communications|February 6, 2019
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Brian Meehan, Zheng Fu, et al.
Nature Cancer|February 5, 2022
Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigrationSheri A C McDowell, Robin B E Luo, Azadeh Arabzadeh, et al.
Cancer Discovery|September 14, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform TrialTina Cascone, Gozde Kar, Jonathan D Spicer, et al.
The New England Journal of Medicine|May 15, 2024
Perioperative Nivolumab in Resectable Lung CancerTina Cascone, Mark M Awad, Jonathan D Spicer, et al.
The Journal of Experimental Medicine|May 11, 2023
Obesity alters monocyte developmental trajectories to enhance metastasisSheri A C McDowell, Simon Milette, Samuel Doré, et al.
Nature|December 3, 2025
Architecture of the neutrophil compartmentDaniela Cerezo-Wallis, Andrea Rubio-Ponce, Mathis Richter, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The New England Journal of Medicine|June 2, 2025
Overall Survival with Neoadjuvant Nivolumab plus Chemotherapy in Lung CancerPatrick M Forde, Jonathan D Spicer, Mariano Provencio, et al.
Nature Communications|February 6, 2019
SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancerYibo Xue, Brian Meehan, Zheng Fu, et al.
Nature Cancer|February 5, 2022
Neutrophil oxidative stress mediates obesity-associated vascular dysfunction and metastatic transmigrationSheri A C McDowell, Robin B E Luo, Azadeh Arabzadeh, et al.
Cancer Discovery|September 14, 2023
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform TrialTina Cascone, Gozde Kar, Jonathan D Spicer, et al.
The New England Journal of Medicine|May 15, 2024
Perioperative Nivolumab in Resectable Lung CancerTina Cascone, Mark M Awad, Jonathan D Spicer, et al.
The Journal of Experimental Medicine|May 11, 2023
Obesity alters monocyte developmental trajectories to enhance metastasisSheri A C McDowell, Simon Milette, Samuel Doré, et al.
Nature|December 3, 2025
Architecture of the neutrophil compartmentDaniela Cerezo-Wallis, Andrea Rubio-Ponce, Mathis Richter, et al.
Pageof 8